These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 34954051)

  • 21. Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test.
    Takano R; Sugano K; Higashida A; Hayashi Y; Machida M; Aso Y; Yamashita S
    Pharm Res; 2006 Jun; 23(6):1144-56. PubMed ID: 16715363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current status and future opportunities for incorporation of dissolution data in PBPK modeling for pharmaceutical development and regulatory applications: OrBiTo consortium commentary.
    Jamei M; Abrahamsson B; Brown J; Bevernage J; Bolger MB; Heimbach T; Karlsson E; Kotzagiorgis E; Lindahl A; McAllister M; Mullin JM; Pepin X; Tistaert C; Turner DB; Kesisoglou F
    Eur J Pharm Biopharm; 2020 Oct; 155():55-68. PubMed ID: 32781025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IMI - Oral biopharmaceutics tools project - Evaluation of bottom-up PBPK prediction success part 4: Prediction accuracy and software comparisons with improved data and modelling strategies.
    Ahmad A; Pepin X; Aarons L; Wang Y; Darwich AS; Wood JM; Tannergren C; Karlsson E; Patterson C; Thörn H; Ruston L; Mattinson A; Carlert S; Berg S; Murphy D; Engman H; Laru J; Barker R; Flanagan T; Abrahamsson B; Budhdeo S; Franek F; Moir A; Hanisch G; Pathak SM; Turner D; Jamei M; Brown J; Good D; Vaidhyanathan S; Jackson C; Nicolas O; Beilles S; Nguefack JF; Louit G; Henrion L; Ollier C; Boulu L; Xu C; Heimbach T; Ren X; Lin W; Nguyen-Trung AT; Zhang J; He H; Wu F; Bolger MB; Mullin JM; van Osdol B; Szeto K; Korjamo T; Pappinen S; Tuunainen J; Zhu W; Xia B; Daublain P; Wong S; Varma MVS; Modi S; Schäfer KJ; Schmid K; Lloyd R; Patel A; Tistaert C; Bevernage J; Nguyen MA; Lindley D; Carr R; Rostami-Hodjegan A
    Eur J Pharm Biopharm; 2020 Nov; 156():50-63. PubMed ID: 32805361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrating drug permeability with dissolution profile to develop IVIVC.
    Takano R; Kataoka M; Yamashita S
    Biopharm Drug Dispos; 2012 Oct; 33(7):354-65. PubMed ID: 22581486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Sensitive Medium-Throughput Method to Predict Intestinal Absorption in Humans Using Rat Intestinal Tissue Segments.
    Da Silva LC; Da Silva TL; Antunes AH; Rezende KR
    J Pharm Sci; 2015 Sep; 104(9):2807-12. PubMed ID: 25690454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Approaches to Account for Colon Absorption in Physiologically Based Biopharmaceutics Modeling of Extended-Release Drug Products.
    Jadhav H; Augustijns P; Tannergren C
    Mol Pharm; 2023 Dec; 20(12):6272-6288. PubMed ID: 37902586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study.
    Kuentz M; Nick S; Parrott N; Röthlisberger D
    Eur J Pharm Sci; 2006 Jan; 27(1):91-9. PubMed ID: 16219449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of data mining approach to identify drug subclasses based on solubility and permeability.
    Gatarić B; Parojčić J
    Biopharm Drug Dispos; 2019 Feb; 40(2):51-61. PubMed ID: 30635908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Model-Based Analysis of Biopharmaceutic Experiments To Improve Mechanistic Oral Absorption Modeling: An Integrated in Vitro in Vivo Extrapolation Perspective Using Ketoconazole as a Model Drug.
    Pathak SM; Ruff A; Kostewicz ES; Patel N; Turner DB; Jamei M
    Mol Pharm; 2017 Dec; 14(12):4305-4320. PubMed ID: 28771009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of a Caco-2 microfluidic Chip model for predicting intestinal absorption of BCS Class I-IV drugs.
    Zhang SY; Ong WSY; Subelzu N; Gleeson JP
    Int J Pharm; 2024 May; 656():124089. PubMed ID: 38599444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is the full potential of the biopharmaceutics classification system reached?
    Bergström CA; Andersson SB; Fagerberg JH; Ragnarsson G; Lindahl A
    Eur J Pharm Sci; 2014 Jun; 57():224-31. PubMed ID: 24075971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resolving intraluminal drug and formulation behavior: Gastrointestinal concentration profiling in humans.
    Brouwers J; Augustijns P
    Eur J Pharm Sci; 2014 Sep; 61():2-10. PubMed ID: 24495579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption.
    Yu LX; Lipka E; Crison JR; Amidon GL
    Adv Drug Deliv Rev; 1996 Jun; 19(3):359-76. PubMed ID: 11540095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physiologically Based Biopharmaceutics Modeling of Regional and Colon Absorption in Dogs.
    Eckernäs E; Tannergren C
    Mol Pharm; 2021 Apr; 18(4):1699-1710. PubMed ID: 33720733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of regional differences along the gastrointestinal tract of healthy adults on oral drug absorption: An UNGAP review.
    Vertzoni M; Augustijns P; Grimm M; Koziolek M; Lemmens G; Parrott N; Pentafragka C; Reppas C; Rubbens J; Van Den Αbeele J; Vanuytsel T; Weitschies W; Wilson CG
    Eur J Pharm Sci; 2019 Jun; 134():153-175. PubMed ID: 30991092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biopharmaceutic classification of drugs revisited.
    Daousani C; Macheras P
    Eur J Pharm Sci; 2016 Dec; 95():82-87. PubMed ID: 27496048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral biopharmaceutics-current status and identified gaps of understanding.
    Lennernäs H; Abrahamsson P; Langguth B
    Eur J Pharm Sci; 2014 Jun; 57():98. PubMed ID: 24508580
    [No Abstract]   [Full Text] [Related]  

  • 38. Revising Pharmacokinetics of Oral Drug Absorption: I Models Based on Biopharmaceutical/Physiological and Finite Absorption Time Concepts.
    Macheras P; Chryssafidis P
    Pharm Res; 2020 Sep; 37(10):187. PubMed ID: 32888087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro testing of drug absorption for drug 'developability' assessment: forming an interface between in vitro preclinical data and clinical outcome.
    Sun D; Yu LX; Hussain MA; Wall DA; Smith RL; Amidon GL
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):75-85. PubMed ID: 14982151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of physiological intestinal water in oral absorption.
    Sutton SC
    AAPS J; 2009 Jun; 11(2):277-85. PubMed ID: 19412669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.